Ulisse S, Gionchetti P, D'Alò S, Russo F P, Pesce I, Ricci G, Rizzello F, Helwig U, Cifone M G, Campieri M, De Simone C
Department of Experimental Medicine, University of L'Aquila, Italy.
Am J Gastroenterol. 2001 Sep;96(9):2691-9. doi: 10.1111/j.1572-0241.2001.04139.x.
The efficacy of probiotic organisms in the treatment of pouchitis has been reported. In the present study, we evaluated the tissue levels of pro- and anti-inflammatory cytokines, nitric oxide synthase, and matrix metalloproteinases in control and inflamed pouches before and after antibiotic and probiotic treatment of patients with acute pouchitis.
Pouch biopsy samples were obtained from seven patients with pouchitis before and after antibiotic and probiotic treatment. Tissue samples from five patients with normal pouches were used as controls. Cytokines were determined by ELISA, matrix metalloproteinase activity was evaluated by zymograms, and nitric oxide synthase activity was determined by measuring arginine to citrulline conversion.
Tissue levels of tumor necrosis factor a increased (p < 0.01) in pouchitis relative to uninflamed pouches and reduced after antibiotic and probiotic treatment. Also, interferon y and interleukin 1alpha (IL-1alpha) augmented in pouchitis, but their increase did not reach statistical significance. The latter, however, were lower (p < 0.05) after treatment with the antibiotics and probiotics. Tissue levels of IL-4 and IL-10 were unchanged in inflamed pouches and unaffected by antibiotic treatment. However, IL-10 increased (p < 0.05) after probiotic treatment. Moreover, inflamed pouches had higher levels of inducible nitric oxide synthase and gelatinase activities, which decreased after treatment.
The ability of antibiotic and probiotic treatments to increase tissue levels of IL-10, at a higher level than those observed in control pouches, and to decrease, to levels present in control pouches, proinflammatory cytokine, inducible nitric oxide synthase, and matrix metalloproteinase activity may suggest a mechanism of action to explain the efficacy of this therapeutic regime in pouchitis.
已有报道益生菌在治疗袋炎方面的疗效。在本研究中,我们评估了急性袋炎患者在接受抗生素和益生菌治疗前后,对照袋和发炎袋中促炎和抗炎细胞因子、一氧化氮合酶及基质金属蛋白酶的组织水平。
从7例袋炎患者接受抗生素和益生菌治疗前后获取袋活检样本。将5例正常袋患者的组织样本用作对照。通过酶联免疫吸附测定法测定细胞因子,通过酶谱法评估基质金属蛋白酶活性,通过测量精氨酸向瓜氨酸的转化来测定一氧化氮合酶活性。
与未发炎的袋相比,袋炎中肿瘤坏死因子α的组织水平升高(p<0.01),在抗生素和益生菌治疗后降低。此外,干扰素γ和白细胞介素1α(IL-1α)在袋炎中增加,但其增加未达到统计学意义。然而,在使用抗生素和益生菌治疗后,后者较低(p<0.05)。发炎袋中IL-4和IL-10的组织水平未改变,且不受抗生素治疗影响。然而,益生菌治疗后IL-10增加(p<0.05)。此外,发炎袋中诱导型一氧化氮合酶和明胶酶活性水平较高,治疗后降低。
抗生素和益生菌治疗能够使IL-10的组织水平升高,且高于对照袋中的水平,并能将促炎细胞因子、诱导型一氧化氮合酶和基质金属蛋白酶活性降低至对照袋中的水平,这可能提示了一种作用机制,用以解释该治疗方案在袋炎中的疗效。